{"id":751094,"date":"2023-04-25T17:25:57","date_gmt":"2023-04-25T21:25:57","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/supernus-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-on-may-9-2023\/"},"modified":"2023-04-25T17:25:57","modified_gmt":"2023-04-25T21:25:57","slug":"supernus-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-on-may-9-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/supernus-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-on-may-9-2023\/","title":{"rendered":"Supernus Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call on May 9, 2023"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">ROCKVILLE, Md., April  25, 2023  (GLOBE NEWSWIRE) &#8212; Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company expects to report financial and business results for the first quarter of 2023 after the market closes on Tuesday, May 9, 2023.<\/p>\n<p align=\"justify\">Jack Khattar, President and CEO, and Tim Dec, Senior Vice President and CFO, will host a conference call to present the first quarter 2023 financial and business results on Tuesday, May 9, 2023, at 4:30 p.m. ET. Following management\u2019s prepared remarks and discussion of business results, the call will be open for questions.<\/p>\n<p align=\"justify\">A live webcast will be accessible in the Events &amp; Presentations section of the Company\u2019s Investor Relations website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RgQDhp_3NqoAoB7o86dtvPpXWkypHPpGRIbXSDWgb3lQh3Htri9naIFP9SpJ5xFH5SjHBuofNr5vMQaHr-zy7cDvBVqAaYBfRFgiPqSLZwhV9KZkHb4cmvAZt4wU8JoH\" rel=\"nofollow noopener\" target=\"_blank\">www.supernus.com\/investors<\/a>.<\/p>\n<p align=\"justify\">Participants may also pre-register any time before the call <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=29Pqm9wdGwxhfa9jI-fyDNt6_Nf9QLrp6BvpmpOwTB-9CN2Vv4eic1xosUz-HoG756HnaA-ntToYpC03GSExipB-ypXySzCWpHIuQzT4DGmsxZ31Zxkuk50hwbXdFxZap31zieJ7arvEmtogqvvR1w==\" rel=\"nofollow noopener\" target=\"_blank\">here<\/a>. Once registration is completed, participants will be provided a dial-in number with a personalized conference code to access the call. Please dial in 15 minutes prior to the start time.<\/p>\n<p align=\"justify\">Following the live call, a replay will be available on the Company&#8217;s Investor Relations website <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RgQDhp_3NqoAoB7o86dtvPpXWkypHPpGRIbXSDWgb3nzAdZAGlfsJO_zDTVGwjSjVcWmdzIAu7wQXjNmJheUVPKIfzlsAQQkow1E1ri_If8kAcQr3Vt4PH8i-n07_4DC\" rel=\"nofollow noopener\" target=\"_blank\">www.supernus.com\/investors<\/a>. The webcast will be available on the Company\u2019s website for 60 days following the live call.<\/p>\n<p align=\"justify\">\n        <strong>About Supernus Pharmaceuticals, Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">Supernus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases.<\/p>\n<p align=\"justify\">Our diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, ADHD, hypomobility in Parkinson\u2019s disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. We are developing a broad range of novel CNS product candidates including new potential treatments for hypomobility in PD, epilepsy, depression, and other CNS disorders.<\/p>\n<p align=\"justify\">For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RgQDhp_3NqoAoB7o86dtvAgexjRDCtdNwPP-VAMrKhyrSaH3P_mv0q8uWXk9BVGjlpmDJ5wNGLv0GUG5JaToUQ==\" rel=\"nofollow noopener\" target=\"_blank\">www.supernus.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>CONTACTS:<\/strong>\n      <\/p>\n<p align=\"justify\">Jack A. Khattar, President and CEO <br \/>Timothy C. Dec, Senior Vice President and CFO<br \/>Supernus Pharmaceuticals, Inc.<br \/>Tel: (301) 838-2591<\/p>\n<p align=\"justify\">or<\/p>\n<p align=\"justify\">INVESTOR CONTACT:<br \/>Peter Vozzo<br \/>ICR Westwicke<br \/>Office: (443) 213-0505<br \/>Mobile: (443) 377-4767<br \/>Email: peter.vozzo@westwicke.com<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNTM2NCM1NTMzMzE1IzIwMTA5NDI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NGU5NGQ3OGItZGUxMS00ZWNlLTgwMzctMjMzNjJhMmM5YjAxLTEwMjI1MTU=\/tiny\/Supernus-Pharmaceuticals-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ROCKVILLE, Md., April 25, 2023 (GLOBE NEWSWIRE) &#8212; Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company expects to report financial and business results for the first quarter of 2023 after the market closes on Tuesday, May 9, 2023. Jack Khattar, President and CEO, and Tim Dec, Senior Vice President and CFO, will host a conference call to present the first quarter 2023 financial and business results on Tuesday, May 9, 2023, at 4:30 p.m. ET. Following management\u2019s prepared remarks and discussion of business results, the call will be open for questions. A live webcast will be accessible in the Events &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/supernus-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-on-may-9-2023\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Supernus Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call on May 9, 2023&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-751094","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Supernus Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call on May 9, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/supernus-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-on-may-9-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Supernus Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call on May 9, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ROCKVILLE, Md., April 25, 2023 (GLOBE NEWSWIRE) &#8212; Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company expects to report financial and business results for the first quarter of 2023 after the market closes on Tuesday, May 9, 2023. Jack Khattar, President and CEO, and Tim Dec, Senior Vice President and CFO, will host a conference call to present the first quarter 2023 financial and business results on Tuesday, May 9, 2023, at 4:30 p.m. ET. Following management\u2019s prepared remarks and discussion of business results, the call will be open for questions. A live webcast will be accessible in the Events &hellip; Continue reading &quot;Supernus Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call on May 9, 2023&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/supernus-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-on-may-9-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-25T21:25:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNTM2NCM1NTMzMzE1IzIwMTA5NDI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/supernus-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-on-may-9-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/supernus-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-on-may-9-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Supernus Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call on May 9, 2023\",\"datePublished\":\"2023-04-25T21:25:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/supernus-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-on-may-9-2023\\\/\"},\"wordCount\":342,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/supernus-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-on-may-9-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNTM2NCM1NTMzMzE1IzIwMTA5NDI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/supernus-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-on-may-9-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/supernus-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-on-may-9-2023\\\/\",\"name\":\"Supernus Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call on May 9, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/supernus-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-on-may-9-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/supernus-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-on-may-9-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNTM2NCM1NTMzMzE1IzIwMTA5NDI=\",\"datePublished\":\"2023-04-25T21:25:57+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/supernus-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-on-may-9-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/supernus-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-on-may-9-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/supernus-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-on-may-9-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNTM2NCM1NTMzMzE1IzIwMTA5NDI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNTM2NCM1NTMzMzE1IzIwMTA5NDI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/supernus-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-on-may-9-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Supernus Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call on May 9, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Supernus Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call on May 9, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/supernus-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-on-may-9-2023\/","og_locale":"en_US","og_type":"article","og_title":"Supernus Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call on May 9, 2023 - Market Newsdesk","og_description":"ROCKVILLE, Md., April 25, 2023 (GLOBE NEWSWIRE) &#8212; Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company expects to report financial and business results for the first quarter of 2023 after the market closes on Tuesday, May 9, 2023. Jack Khattar, President and CEO, and Tim Dec, Senior Vice President and CFO, will host a conference call to present the first quarter 2023 financial and business results on Tuesday, May 9, 2023, at 4:30 p.m. ET. Following management\u2019s prepared remarks and discussion of business results, the call will be open for questions. A live webcast will be accessible in the Events &hellip; Continue reading \"Supernus Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call on May 9, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/supernus-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-on-may-9-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-04-25T21:25:57+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNTM2NCM1NTMzMzE1IzIwMTA5NDI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/supernus-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-on-may-9-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/supernus-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-on-may-9-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Supernus Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call on May 9, 2023","datePublished":"2023-04-25T21:25:57+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/supernus-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-on-may-9-2023\/"},"wordCount":342,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/supernus-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-on-may-9-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNTM2NCM1NTMzMzE1IzIwMTA5NDI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/supernus-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-on-may-9-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/supernus-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-on-may-9-2023\/","name":"Supernus Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call on May 9, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/supernus-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-on-may-9-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/supernus-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-on-may-9-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNTM2NCM1NTMzMzE1IzIwMTA5NDI=","datePublished":"2023-04-25T21:25:57+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/supernus-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-on-may-9-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/supernus-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-on-may-9-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/supernus-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-on-may-9-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNTM2NCM1NTMzMzE1IzIwMTA5NDI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNTM2NCM1NTMzMzE1IzIwMTA5NDI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/supernus-pharmaceuticals-to-announce-first-quarter-2023-financial-results-and-host-conference-call-on-may-9-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Supernus Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call on May 9, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/751094","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=751094"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/751094\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=751094"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=751094"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=751094"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}